Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation.

求助中 10 由 Holly 发布于 2024/10/10 10:30:36

DOI:10.1056/NEJMoa2401304
作者：Surya P Bhatt,?Klaus F Rabe,?Nicola A Hanania,?Claus F Vogelmeier,?Mona Bafadhel,?Stephanie A Christenson,?Alberto Papi,?Dave Singh,?Elizabeth Laws,?Naimish Patel,?George D Yancopoulos,?Bolanle Akinla
文献类型：期刊论文
补充材料：只需要正文

New England Journal of Medicine (NEJM)

Abstract：Background: Dupilumab, a fully human monoclonal antibody that blocks the shared receptor component for interleukin-4 and interleukin-13, key and central drivers of type 2 inflammation, has s

应助信息

等您来应助

上传文件

4小时前

Book学术机器人

2024/10/10 10:30:36 未找到该文献，机器人已退出，请等待人工下载

2024/10/10 10:30:36 Book学术AI机器人收到请求，开始寻找文献

2024/10/10 10:30:36 已向机器人发送请求

4小时前

Holly 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Synaptic mitochondria glycation contributes to mitochondrial stress and cognitive dysfunction.